AM-9635 is a selective PI3Kδ inhibitor with oral bioavailability and favorable in vitro and in vivo activity and pharmacodynamic properties; it inhibits PI3Kδ-dependent B-cell receptor-mediated AKT phosphorylation and suppresses the production of antigen-specific IgG and IgM antibodies in keyhole limpet hemocyanin (KLH)-immunized rats.